Livonia, Mich.-based Trinity Well being, one of many largest nonprofit hospital teams within the nation, is issuing $50 million of latest bonds each to finance new tasks and to assist refinance present ones.
The transaction, dated Dec. 7, has an preliminary rate of interest of three.62 p.c and the bond will mature Dec. 1, 2052.
Trinity, which acquired MercyOne Well being in one of many bigger hospital transactions this 12 months, operates throughout 26 states in 88 hospitals plus a number of different places.
The corporate had its credit standing affirmed at “AA-” even because it posted an general lack of $1.4 billion in fiscal 2022, Fitch stated Dec. 1.
After decades of halting advances, the field of Accessibility for people with disabilities has reached not a fork in one road—it’s smack in the middle of a bustling (and often contentious) convergence of many forces from many directions.
There are imperatives from legal and moral to societal and financial. Disabilities physical, sensory and cognitive. Politics and profit. Them, me. All crashing into each other in ways never seen before.
There is little consensus on where accessibility will emerge from all this. But if experts agree on anything, it’s that the business community will play a significant role. Progress will rely on good, old-fashioned entrepreneurship and investment in AI-driven communication devices, exoskeletons, consumer products and much more.
“Accessibility has been an ignored space from investment capital,” says Paul Kent, the managing partner of the Disabled Life Alliance, which connects and facilitates deals between private investors and innovators in the accessibility space. “It’s been thought of as a small market, which is ridiculous. There’s a massive return associated with this. A lot of people believe social impact requires less than market-rate returns. But that’s not true. This is not charity. It’s an investible market.”
Advertisement
Forbes’ inaugural Accessibility 100 list gives a unique look at the industry as it stands today, and where it’s headed. The list features the top innovators and impact-makers—from large companies to lone inventors—in sectors like mobility, communication, sports, entertainment and many more. Some make devices like “smart canes” that can tell blind users where things are, from poles to the Starbucks entrance; while others build playgrounds for disabled children, or provide access from everything to the beach, the ballot box and a career in modeling. Profiles of all 100 appear on pages devoted to those categories; for example, education is here.
Featuring companies and people from 15 countries, the list was compiled through more than 400 conversations with industry insiders over nine months, and with the guidance of an expert advisory board. Disabilities considered include physical, sensory and neurodivergent; types of accessibility include digital (technology, websites and so on), physical (access to public transportation and buildings) and experiences (sports, careers and the like). Emphasis was placed on breadth of impact felt now and expected in the near future. This page details the list’s methodology and advisory board.
Current debates over DEI (often called DEIA, the A for accessibility) often overlook one dynamic: the disabled community is the one minority which anyone of any race, gender, age or financial means can suddenly find themselves thrust into. The head of accessibility at a major communications company, who asked not to be identified given the current political climate, calls accessibility a “casualty of war” over DEI policies—such as when the Trump administration stopped providing sign-language interpretation during broadcasts of press briefings, cutting them off to deaf and hard-of-hearing citizens. (The National Association of the Deaf immediately sued.) Likewise, stricter protections for disabled airline travelers instituted by the previous administraion—such as reimbursement for wheelchair damage and better training for flight personnel to increase safety—have been opposed by the airline industry, which is now seeking to delay, dilute, or remove them altogether.
As such conflicts play out, companies and entrepreneurs currently changing the world of accessibility are, in ways surprisingly new, inviting people with all disabilities into design conversations and testing labs, heeding the community’s mantra, “Nothing about us without us.” Recently, as sign-language robotic hands were hailed by outsiders as possibly replacing expensive interpreters—a certainly worthwhile goal—the enthusiasm has obscured the reality that they didn’t really serve the deaf and hard-of-hearing community yet.
“American Sign Language is 70 percent what we call nonverbal markers—it’s your face, how your body moves, not just hand shapes,” says Kelby Brick, the chief operating officer of the National Federation of the Deaf. Usable innovation in the area, he suspects, would require AI-driven avatars that can convey that nuance.
Advertisement
Not all advancements in accessibility are contentious. Many become universal. Closed captioning—originally designed for the deaf—has grown so ubiquitous that it has became one of many examples of what is now called “the curb-cut effect,” so named after sloped curbs designed for people with disabilities wound up benefitting everyone, like those pushing strollers or pulling suitcases. Other instances include electric toothbrushes, speech-to-text and even bendable straws.
Indeed, the preferred approach for many companies has become “universal design,” where products and services are built from the start to serve everyone, rather than winding up immediately unusable by the disabled or clumsily retrofitted after the fact. Several firms, including Accessibility 100 listmakers Deque and Fable, now produce software that checks computer code as it’s written to ensure that accessibility features work out of the box. OXO, also on the list, is a household name (literally) that designs all of its kitchen products to be easy for everyone, from smooth-turning can openers to tongs that close with one hand.
One distinct feature of accessibility innovation is that companies—even direct competitors—enthusiastically share ideas and advances, even code, to hasten innovation for all. For example, Procter & Gamble invented raised icons that blind and low-vision people can feel to distinguish products like liquid soap, shampoo and laundry detergent from each other; the company is sharing them with others to make them standard. “We’re not just trying to do it alone,” says Sam Latif, P&G’s Company Accessibility Leader. “Doing it on a few products is not as impactful as the industry doing it together.”
Apple operating systems have built accessibility features into its software since the 1980s, but when Steve Jobs insisted that the first iPhone have no buttons—making it almost unusable for blind people—it sparked faster and faster feature innovations, like haptic feedback, screen magnification, suppression of flashing content and hundreds more. There are so many, in fact, that Apple recently introduced App Store “Accessibility Nutrition Labels” to let users know how each app serves their specific disability.
“It makes good business sense to make technology that works for everyone—we mean everyone,” says Sarah Herrlinger, Apple’s top accessibility official. “Accessibility is some of the most creative work we do.”
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01.
A private equity firm has stepped in to finance a biological research lab at Harvard University, administrators said Monday, while also launching a biotech alongside it that will develop new therapies for metabolic conditions.
As Harvard grapples with severe financing cuts undertaken by the Trump administration, some university officials believe the unusual arrangement could be at least one model to fund other academic research in the future.
Under the deal announced Monday, İş Private Equity, a Turkish firm, has committed $39 million to a laboratory run by Gökhan Hotamışlıgil, a professor of genetics and metabolism at the T.H. Chan School of Public Health. The firm, which is a branch of Turkey’s İşbank Group, also plans to invest an undisclosed amount of money in any drug candidates that come out of Hotamışlıgil’s laboratory and are moved into a new biotech called Enlila.
It’s a relatively modest deal, in the scope of investment banking. But the collaboration provides much-needed capital at a time when the model for funding scientific research has been thrown into chaos.
Advertisement
STAT+ Exclusive Story
Already have an account? Log in
Advertisement
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
View All Plans
Advertisement
To read the rest of this story subscribe to STAT+.
Kinatico (ASX:KYP) has had a rough month with its share price down 7.7%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Specifically, we decided to study Kinatico’s ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder’s equity.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
The formula for return on equity is:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity
Advertisement
So, based on the above formula, the ROE for Kinatico is:
3.2% = AU$840k ÷ AU$26m (Based on the trailing twelve months to December 2024).
The ‘return’ is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each A$1 of shareholders’ capital it has, the company made A$0.03 in profit.
See our latest analysis for Kinatico
So far, we’ve learned that ROE is a measure of a company’s profitability. We now need to evaluate how much profit the company reinvests or “retains” for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don’t necessarily bear these characteristics.
Advertisement
It is hard to argue that Kinatico’s ROE is much good in and of itself. Not just that, even compared to the industry average of 5.0%, the company’s ROE is entirely unremarkable. Despite this, surprisingly, Kinatico saw an exceptional 44% net income growth over the past five years. We reckon that there could be other factors at play here. Such as – high earnings retention or an efficient management in place.
Next, on comparing with the industry net income growth, we found that Kinatico’s growth is quite high when compared to the industry average growth of 24% in the same period, which is great to see.
ASX:KYP Past Earnings Growth June 15th 2025
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Has the market priced in the future outlook for KYP? You can find out in our latest intrinsic value infographic research report.
Advertisement
Kinatico doesn’t pay any regular dividends currently which essentially means that it has been reinvesting all of its profits into the business. This definitely contributes to the high earnings growth number that we discussed above.
On the whole, we do feel that Kinatico has some positive attributes. Despite its low rate of return, the fact that the company reinvests a very high portion of its profits into its business, no doubt contributed to its high earnings growth. That being so, the latest analyst forecasts show that the company will continue to see an expansion in its earnings. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.